Cole Windy, Samsell Brian, Moore Mark A
Adjunct Faculty and Director, Wound Care Research, Kent State University College of Podiatric Medicine, Independence, OH; Medical Director, Wound Care Center, University Hospitals Ahuja Medical Center, Beachwood, OH.
Scientific Writer, Scientific Affairs, LifeNet Health, Virginia Beach, VA.
J Foot Ankle Surg. 2018 Nov-Dec;57(6):1225-1229. doi: 10.1053/j.jfas.2018.03.006. Epub 2018 May 18.
Achilles tendon ruptures are common in the general population, especially among members of the older demographic occasionally active in sports. Operative treatments provide a lower incidence of rerupture than do nonoperative treatments, although surgical complications remain a concern. The use of a human acellular dermal matrix to augment Achilles tendon repair might reduce the incidence of complications. In the present case series, we describe the outcomes of 9 patients who underwent Achilles tendon repair with acellular dermal matrix augmentation. Functional outcomes were evaluated using the Foot Function Index-Revised long form, and the clinical results were recorded. After a mean average follow-up period of 14.4 (range 12.0 to 20.0) months, the mean Foot Function Index-Revised long form score was 33.0% ± 4.2%. No cases of rerupture or complications that required additional treatment occurred during the observation period. The outcomes we have presented support further evaluation beyond this case series for using a human acellular dermal matrix to augment Achilles tendon repairs.
跟腱断裂在普通人群中很常见，尤其是在偶尔参加体育活动的老年人群体中。与非手术治疗相比，手术治疗的再断裂发生率较低，尽管手术并发症仍然是一个问题。使用人脱细胞真皮基质增强跟腱修复可能会降低并发症的发生率。在本病例系列中，我们描述了9例接受脱细胞真皮基质增强跟腱修复患者的治疗结果。使用修订后的足功能指数长表评估功能结果，并记录临床结果。平均随访14.4个月（范围12.0至20.0个月）后，修订后的足功能指数长表平均得分33.0%±4.2%。在观察期内未发生需要额外治疗的再断裂或并发症病例。我们所呈现的结果支持在本病例系列之外进一步评估使用人脱细胞真皮基质增强跟腱修复的效果。
